Skip to main content
Premium Trial:

Request an Annual Quote

Mary Jane Cunningham and Jim Sullivan

Premium

Mary Jane Cunningham, the former director of pharmacogenomics at Genometrix of the Woodlands, Texas, is the new director of discoveries at Molecular Mining in Kingston, Ontario. Cunningham developed a microarray-based gene expression database at Genometrix and previously worked at Incyte.

The company has also appointed Jim Sullivan as director of North American sales. Sullivan previously worked for Lion Biosciences as a Northeast US sales representative, as well as at Millipore, Tripos, and Genometrix.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.